The association of USH2A mutations with both structural heart defects (like VSD and now PFO) and sensory disorders (Usher syndrome, keratoconus) suggests that individuals diagnosed with PFO, especially if accompanied by sensory issues, could potentially benefit from genetic screening for USH2A variants, informing broader health management. This evidence concerns the gene USH2A and Patent foramen ovale.